RYAN CHOPLIN: Open Payments
NPI 1760729610 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,964 in 151 payments from 25 companies in 2025. Trend: 2023 $2,368 · 2024 $3,524 · 2025 $2,964
Food & beverage: $2,964
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $613 |
| Novo Nordisk Inc | 19 | $369 |
| ABBVIE INC. | 27 | $333 |
| PFIZER INC. | 16 | $241 |
| Lilly USA, LLC | 12 | $153 |
| Exact Sciences Corporation | 7 | $152 |
| Insulet Corporation | 2 | $151 |
| Axsome Therapeutics, Inc. | 3 | $150 |
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $93 |
Products named: AIRSUPRA, VRAYLAR, FARXIGA, Cologuard Collection Kit, BREZTRI, Omnipod, MOUNJARO, Sunosi.
Industry payments across OK — which companies pay providers there.
